Swiss precision medicines company Haya Therapeutics completed a $65 million series A funding round. In connection with the deal, Kellerhals Carrard represented lead investors Sofinnova Partners and Earlybird Venture Capital, while Lenz & Staehelin assisted Eli
Tags :Tino Gaberthüel
Homburger and Lenz & Staehelin have been recently involved in OC Oerlikon’s divestment of its Barmag textile machinery business for manmade fibers to Rieter. In connection with the deal, Homburger is representing the selling
Lenz & Staehelin is advising Baloise as lead counsel on its merger with Helvetia, which is represented by Walder Wyss. The two Swiss composite insurance groups will join forces, thus combining a business volume of
Swiss building supplier Arbonia completed the sale of its climate division to Midea Electrics, a subsidiary of the Midea Group (Midea). Baker McKenzie Switzerland, in cooperation with other Baker McKenzie offices, advised the selling part,
Walder Wyss advised Anybotics, an AI-driven robotic inspection solutions company, on raising an additional USD 60 million on its latest financing round led by Qualcomm Ventures and Supernova Invest, advised by Lenz & Staehelin. In total,
Lenz & Staehelin advised Navegar on its additional follow-on investment in Swiss-based Dali Discount, a hard discounter in Southeast Asia. Navegar is a Manila-based private equity firm that provides growth capital to established companies. Lenz &
Singapore-based Venturi Partners have invested USD 25 million in the Philippines-focused grocery store chain Dali. Venturi Partners joins Philippines-based private equity firm Navegar, Malaysia-headquartered buyout company Creador, and multilateral lender the Asian Development Bank (ADB). Lenz &
L Catterton, a leading US private equity firm, entered into a definitive agreement to acquire a significant stake in AmaWaterways, a global, award-winning luxury river cruise line, from a consortium of investors led by Certares.
Viatris, a global healthcare company, and Idorsia Ltd, have both announced they have entered into agreements for a significant global research and development collaboration. Viatris will receive exclusive global development and commercialisation rights to two
Amundi signed an agreement to acquire Alpha Associates, a Swiss-based independent asset manager offering private markets multi-manager investment solutions. The transaction is subject to regulatory approvals and expected to close by the third quarter of 2024.
